Stockscreener 앱 받기
3.035
0.66%
-0.015
시간 외 거래:
3.04
0.005
+0.16%
Stereotaxis Inc 주식(STXS)의 최신 뉴스
Can Stereotaxis Inc. stock resist broad market declines2025 Top Gainers & Scalable Portfolio Growth Methods - newser.com
Visualizing Stereotaxis Inc. stock with heatmaps2025 Big Picture & AI Powered Trade Plan Recommendations - newser.com
Published on: 2025-10-21 19:22:31 - newser.com
Automated trading signals detected on Stereotaxis Inc.July 2025 EndofMonth & Accurate Entry and Exit Point Alerts - newser.com
Can Stereotaxis Inc. stock retain market dominanceEarnings Beat & Weekly Watchlist of Top Performers - newser.com
Stereotaxis (NYSE: STXS) sets Q3 2025 results call and webcast information - Stock Titan
What valuation ratios show for Stereotaxis Inc. stockQuarterly Trade Review & Risk Controlled Daily Plans - newser.com
Stereotaxis Rolls Out Synchrony System in EU and Files for FDA Approval - sharewise.com
Can Stereotaxis Inc. stock test all time highsForecast Cut & Free Technical Pattern Based Buy Signals - newser.com
Will Stereotaxis Inc. stock outperform tech sector in 20252025 Market Sentiment & Risk Adjusted Buy and Sell Alerts - newser.com
Is Stereotaxis Inc. stock attractive for income investorsJuly 2025 Short Interest & AI Based Buy and Sell Signals - newser.com
Is Stereotaxis Inc. stock a buy in volatile marketsJuly 2025 Intraday Action & Low Drawdown Trading Strategies - nchmf.gov.vn
Is Stereotaxis Inc. stock a buy on dips2025 Geopolitical Influence & Free Long-Term Investment Growth Plans - nchmf.gov.vn
Stereotaxis Synchrony System Gets European CE Mark; Applies for FDA 510(k) Certification - Diagnostic and Interventional Cardiology
Is Stereotaxis Inc. stock trading near support levelsMarket Activity Summary & Technical Pattern Based Buy Signals - newser.com
Can Stereotaxis Inc. stock continue upward trendMarket Risk Analysis & Growth Oriented Trade Recommendations - newser.com
Stereotaxis Earns EU Nod for Synchrony System, Submits to FDA - Medical Product Outsourcing
How Stereotaxis Inc. stock stacks up against competitors2025 Technical Patterns & Real-Time Buy Signal Notifications - newser.com
Stereotaxis teams with CardioFocus to develop robotic PFA system - MedTech Dive
Stereotaxis Obtains CE Mark in Europe, Files Application to FDA for Synchrony System - MarketScreener
Stereotaxis (STXS) Moves Forward with Synchrony System Approvals - GuruFocus
Stereotaxis obtains CE mark for Synchrony system, files FDA application By Investing.com - Investing.com Canada
Stereotaxis Announces EU Launch and 510(k) Submission for Synchrony System to Modernize Interventional Cath Labs - GlobeNewswire
CE Mark & 510(k) Submission: Stereotaxis Launches Synchrony with 55” 4K Display and SynX Cloud - Stock Titan
Order flow analysis tools used on Stereotaxis Inc.Earnings Recap Summary & Daily Stock Momentum Reports - newser.com
STXS Partners With CardioFocus to Boost Robotic Pulsed Field Ablation - sharewise.com
Stereotaxis, CardioFocus Collab to Advance Robotic Pulsed Field Ablation - Medical Product Outsourcing
Stereotaxis (STXS) Partners with CardioFocus to Develop Robotic PFA Technology - GuruFocus
Stereotaxis and CardioFocus partner to develop robotic PFA technology - Investing.com
Stereotaxis & CardioFocus Collaborate to Advance Robotic Pulsed Field Ablation for Cardiac Arrhythmias - GlobeNewswire
Is Stereotaxis Inc. stock trading at attractive multiplesWeekly Profit Summary & Real-Time Buy Signal Alerts - newser.com
Stereotaxis Inc Stock Analysis and ForecastInstitutional Holding Changes & Free Explosive Portfolio Gains - earlytimes.in
Stereotaxis, Inc. Hits New 52-Week High of $3.58, Marking Key Milestone - Markets Mojo
2.55%
0.77%
자본화:
|
볼륨(24시간):